Naira Baregamian
Overview
Explore the profile of Naira Baregamian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hartmann H, Loberg M, Xu G, Schwarzkopf A, Chen S, Phifer C, et al.
Endocrinology
. 2025 Feb;
166(3).
PMID: 39951495
Tenascin-C (TNC) is a secreted extracellular matrix protein that is highly expressed during embryonic development and re-expressed during wound healing, inflammation, and neoplasia. Studies in developmental models suggest that TNC...
2.
Loberg M, Xu G, Chen S, Chen H, Wahoski C, Caroland K, et al.
bioRxiv
. 2025 Jan;
PMID: 39829764
Thyroid cancer progression from curable well-differentiated thyroid carcinoma to highly lethal anaplastic thyroid carcinoma is distinguished by tumor cell de-differentiation and recruitment of a robust stromal infiltrate. Combining an integrated...
3.
Hartmann H, Loberg M, Xu G, Schwarzkopf A, Chen S, Phifer C, et al.
bioRxiv
. 2024 Nov;
PMID: 39574628
Tenascin-C (TNC) is a secreted extracellular matrix protein that is highly expressed during embryonic development and re-expressed during wound healing, inflammation, and neoplasia. Studies in developmental models suggest that TNC...
4.
Diaz D, Bergdorf K, Loberg M, Phifer C, Xu G, Sheng Q, et al.
Endocrine
. 2024 May;
86(1):114-118.
PMID: 38806891
Background: Anaplastic thyroid carcinoma (ATC) is a highly aggressive malignancy that has consistently shown Wnt/β-catenin (canonical) signaling activation in various study populations. There are currently no targetable treatments for BRAF-wildtype...
5.
Xu G, Loberg M, Gallant J, Sheng Q, Chen S, Lehmann B, et al.
Cell Genom
. 2023 Oct;
3(10):100409.
PMID: 37868034
Genomic and transcriptomic analysis has furthered our understanding of many tumors. Yet, thyroid cancer management is largely guided by staging and histology, with few molecular prognostic and treatment biomarkers. Here,...
6.
Mannoh E, Baregamian N, Thomas G, Solorzano C, Mahadevan-Jansen A
Sci Rep
. 2023 Oct;
13(1):17270.
PMID: 37828222
Accurate intraoperative assessment of parathyroid blood flow is crucial to preserve function postoperatively. Indocyanine green (ICG) angiography has been successfully employed, however its conventional application has limitations. A label-free method...
7.
Sekhar K, Codreanu S, Williams O, Rathmell J, Rathmell W, McLean J, et al.
Front Endocrinol (Lausanne)
. 2023 Jul;
14:1223312.
PMID: 37492197
Introduction: We successfully developed a broad spectrum of patient-derived endocrine organoids (PDO) from benign and malignant neoplasms of thyroid, parathyroid, and adrenal glands. In this study, we employed functionally intact...
8.
Belcher R, Thomas G, Willmon P, Gallant J, Baregamian N, Lopez M, et al.
Laryngoscope
. 2023 Mar;
133(11):3208-3215.
PMID: 36866696
Objectives: Compared to adult patients undergoing thyroid surgery, pediatric patients have higher rates of hypoparathyroidism often related to parathyroid gland (PG) inadvertent injury or devascularization. Previous studies have shown that...
9.
Baregamian N, Sekhar K, Krystofiak E, Vinogradova M, Thomas G, Mannoh E, et al.
Surgery
. 2022 Nov;
173(1):67-75.
PMID: 36400581
Background: Recent advancements in 3-dimensional patient-derived organoid models have revolutionized the field of cancer biology. There is an urgent need for development of endocrine tumor organoid models for medullary thyroid...
10.
Sekhar K, Hanna D, Cyr S, Baechle J, Kuravi S, Balusu R, et al.
Sci Rep
. 2022 Nov;
12(1):19396.
PMID: 36371529
Papillary thyroid carcinoma (PTC) demonstrates significantly reduced patient survival with metastatic progression. Tumor progression can be influenced by metabolism, including antioxidant glutathione (GSH). Glutathione peroxidase 4 (GPX4) is a selenoenzyme...